Reneo Pharmaceuticals, Inc. RPHM
Set alert
18.20 +18.20 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 60.84M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -47.89
- Beta
- 0.22
- Short ratio
- 27.39
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 14.92
- 200-d avg
- 16.09
- 1y target
- 2.25
Financial health
Altman Z-Score
3.70 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -4.1×
FY 2019 5y median -7.0× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 4.4×
FY 2019 5y median 6.0× FY 2025
P/FCF -4.7×
FY 2019 5y median -12.0× FY 2025
EV/EBITDA -3.0×
FY 2019 5y median -6.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -21.1%
FY 2019 5y median -8.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 0.0%
FY 2019 5y median -27.0% FY 2025
ROIC 0.0%
FY 2019 5y median -26.9% FY 2025
ROA 0.0%
FY 2019 5y median -25.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -15.7%
FY 2019 FY 2025
EPS (diluted) 0.0%
FY 2019 FY 2025
Free Cash Flow -1.4%
FY 2019 FY 2025
Financial Health
Current Ratio 10.3×
FY 2019 5y median 10.7× FY 2025
Quick Ratio 10.3×
FY 2019 5y median 10.7× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 7869×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31